Genetic test that predicts cognitive decline available soon

2021 06 23 21 28 5659 Woman Dementia Alzheimer 400

A genetic test that uses a saliva or blood sample to predict a person's risk of cognitive decline due to Alzheimer's disease is expected to be available to doctors in the coming months.

The test, genoScore, is a collaboration between Infinity BiologiX and Cytox and can be used to assess patients before symptoms arise and prior to invasive cerebrospinal fluid testing. Additionally, the test gives patients the convenience of collecting samples at home.

Page 1 of 163
Next Page